Uropass 0.4 mg (Capsule (Modified Release))
Unit Price: ৳ 10.07 (5 x 4: ৳ 201.40)
Strip Price: ৳ 40.28
Medicine Details
Category | Details |
---|---|
Generic | Tamsulosin hydrochloride |
Company | Acme laboratories ltd |
Indications
- Treatment of functional symptoms of Benign Prostatic Hyperplasia (BPH)
Pharmacology
- Selective alpha1 adrenoceptor blocking agent
- Relaxation of smooth muscle in bladder neck and prostate
- Improvement in urine flow rate
- Reduction in symptoms of BPH
- Absorption of Tamsulosin hydrochloride capsule 0.4mg
- Plasma protein binding (94% to 99%)
- Metabolism by cytochrome P450 enzymes
- Elimination half-life in plasma (five to seven hours)
- Apparent half-life in healthy volunteers
- Apparent half-life in target population
Dosage & Administration
- Tamsulosin Hydrochloride 0.4 mg (one capsule) daily
- Tamsulosin Hydrochloride 0.8 mg (two capsules) once daily
- Dosing after meal at night
- Swallowing whole with a glass of water
- Avoiding crushing or chewing
Interaction
- Concurrent administration of other alfa1-adrenoceptor antagonists
- No interactions with atenolol, enalapril, nifedipine
- Interactions with cimetidine and frusemide
- No interactions at the level of hepatic metabolism
- Potential interactions with diclofenac and warfarin
Contraindications
- Hypersensitivity
- History of orthostatic hypotension
- Severe hepatic insufficiency
- Reduction in blood pressure
- Syncope
- Pre-therapy examination
- Digital rectal examination
- Prostate Specific Antigen (PSA) determination
Side Effects
- Dizziness
- Abnormal ejaculation
- Headache
- Asthenia
- Postural hypotension
- Palpitations
Pregnancy & Lactation
- Not recommended
Precautions & Warnings
- Transient postural symptoms
- Use in patients with micturition syncope not advised
- Effects on ability to drive and use machines
Overdose Effects
- Acute hypotension
- Cardiovascular support
- Volume expanders
- Vasopressors
- Renal function monitoring
- General supportive measures
- Dialysis unlikely to be of help
- Measures to impede absorption
Therapeutic Class
- BPH/ Urinary retention/ Urinary incontinence
Storage Conditions
- Cool and dry place
- Below 30°C
- Protected from light
Related Brands
- Flonor 0.4 mg (Capsule (Modified Release)) - novo-healthcare-and-pharma-ltd
- Maxflo-U 0.4 mg (Capsule (Modified Release)) - rangs-pharmaceuticals-ltd
- Tamfast 0.4 mg (Capsule (Modified Release)) - radiant-pharmaceuticals-ltd
- Prostacin 0.4 mg (Capsule (Modified Release)) - incepta-pharmaceuticals-ltd
- Prostam 0.4 mg (Capsule (Modified Release)) - drug-international-ltd